| Sarah Zinkel, | |
|
1891 Station Pkwy Nw, Andover, MN 55304 | |
| (763) 755-4275 | |
| Not Available |
| Full Name | Sarah Zinkel |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 17 Years |
| Location | 1891 Station Pkwy Nw, Andover, Minnesota |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437335643 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 103540 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Family Speech And Therapy Services Llc | 8022335397 | 5 |
News Archive
Because infectious microorganisms are becoming increasingly resistant to antibiotics, a Wayne State University researcher has joined a nationwide effort to monitor that resistance while optimizing the use of existing drugs.
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped one treatment within a large, ongoing North American clinical trial of diabetes and cardiovascular disease 18 months early due to safety concerns after review of available data, although the study will continue.
Researchers from the Peter O'Donnell Jr. Brain Institute will participate in a national study to determine whether medical devices used in the home can diagnose sleep apnea that often develops after traumatic brain injuries.
Highland Therapeutics, Inc., a specialty pharmaceutical company based in the MaRS Discovery District in Toronto, today announced that its wholly owned subsidiary has generated positive Phase-1 results for HLD-200 - a novel formulation of methylphenidate being developed to treat the symptoms associated with Attention-Deficit/Hyperactivity Disorder.
In Alzheimer's disease, a protein (peptide) forms clumps in the brain and causes sufferers to lose their memory. In a recently published article, a research group at Uppsala University described a new treatment method that increases the body's own degradation of the building blocks that lead to these protein clumps.
› Verified 1 days ago
| Provider Name | Family Speech & Therapy Services Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235285966 PECOS PAC ID: 8022335397 Enrollment ID: O20150325001650 |
News Archive
Because infectious microorganisms are becoming increasingly resistant to antibiotics, a Wayne State University researcher has joined a nationwide effort to monitor that resistance while optimizing the use of existing drugs.
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped one treatment within a large, ongoing North American clinical trial of diabetes and cardiovascular disease 18 months early due to safety concerns after review of available data, although the study will continue.
Researchers from the Peter O'Donnell Jr. Brain Institute will participate in a national study to determine whether medical devices used in the home can diagnose sleep apnea that often develops after traumatic brain injuries.
Highland Therapeutics, Inc., a specialty pharmaceutical company based in the MaRS Discovery District in Toronto, today announced that its wholly owned subsidiary has generated positive Phase-1 results for HLD-200 - a novel formulation of methylphenidate being developed to treat the symptoms associated with Attention-Deficit/Hyperactivity Disorder.
In Alzheimer's disease, a protein (peptide) forms clumps in the brain and causes sufferers to lose their memory. In a recently published article, a research group at Uppsala University described a new treatment method that increases the body's own degradation of the building blocks that lead to these protein clumps.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Zinkel, 17985 69th Pl N, Maple Grove, MN 55311-2966 Ph: () - | Sarah Zinkel, 1891 Station Pkwy Nw, Andover, MN 55304 Ph: (763) 755-4275 |
News Archive
Because infectious microorganisms are becoming increasingly resistant to antibiotics, a Wayne State University researcher has joined a nationwide effort to monitor that resistance while optimizing the use of existing drugs.
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped one treatment within a large, ongoing North American clinical trial of diabetes and cardiovascular disease 18 months early due to safety concerns after review of available data, although the study will continue.
Researchers from the Peter O'Donnell Jr. Brain Institute will participate in a national study to determine whether medical devices used in the home can diagnose sleep apnea that often develops after traumatic brain injuries.
Highland Therapeutics, Inc., a specialty pharmaceutical company based in the MaRS Discovery District in Toronto, today announced that its wholly owned subsidiary has generated positive Phase-1 results for HLD-200 - a novel formulation of methylphenidate being developed to treat the symptoms associated with Attention-Deficit/Hyperactivity Disorder.
In Alzheimer's disease, a protein (peptide) forms clumps in the brain and causes sufferers to lose their memory. In a recently published article, a research group at Uppsala University described a new treatment method that increases the body's own degradation of the building blocks that lead to these protein clumps.
› Verified 1 days ago
Ellen Johnson, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1891 Station Pkwy Nw, Andover, MN 55304 Phone: 763-755-4275 | |
Lisa Michelle Luke, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1891 Station Pkwy Nw, Andover, MN 55304 Phone: 763-755-4275 | |
Mrs. Gina Maria Frattalone Bigelbach, MAOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1891 Station Pkwy Nw, Andover, MN 55304 Phone: 763-755-4275 Fax: 763-755-4261 | |
Suzanne Berg, M.S. OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1891 Station Pkwy Nw, Andover, MN 55304 Phone: 763-755-4275 Fax: 763-755-4261 | |
Nicole Elaine Mold, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1891 Station Pkwy Nw, Andover, MN 55304 Phone: 763-755-4275 | |
Laura Bollig, M.A., OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1891 Station Pkwy Nw, Andover, MN 55304 Phone: 763-755-4275 | |
Shelly Sontag-johnson, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1891 Station Pkwy Nw, Andover, MN 55304 Phone: 763-755-4275 |